GRAIL, Inc. (GRAL)
59.65
-2.15
(-3.48%)
USD |
NASDAQ |
May 15, 16:00
59.70
+0.05
(+0.08%)
After-Hours: 20:00
GRAIL EPS Diluted (Quarterly) : -2.293 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veracyte, Inc. | 0.353 |
| Insight Molecular Diagnostics, Inc. | -0.1243 |
| Exagen, Inc. | -0.1663 |
| bioAffinity Technologies, Inc. | -0.8077 |
| Biodesix, Inc. | -0.8071 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -93.19M |
| Revenue (Quarterly) | 40.78M |
| Total Expenses (Quarterly) | 133.97M |
| Enterprise Value | 1.788B |
| Gross Profit Margin (Quarterly) | -37.81% |
| Profit Margin (Quarterly) | -228.5% |
| Earnings Yield | -17.39% |
| Normalized Earnings Yield | -16.48 |